The Global Liquid Biopsy Market 2018 To 2022 Business Overview:
Liquid biopsy is one of the promising non-invasive methods for the diagnosis of cancer. It involves the sampling of tissue in the liquid state. It is a simple and painless method for cancer diagnostic as compared to other diagnostics methods. Therefore, liquid as well as solid biopsy is important for cancer management, and creates excellent growth opportunities in the market.
The technology is further applicable for monitoring cardiac and neurologic disease, early detection and evaluation of drug resistance, and prenatal testing. It can now be applied to organ transplant monitoring to bridge the gap between need of new technology, and rising demand.
Get Exclusive Sample Copy @ https://www.marketresearchfuture.com/sample_request/710 .
Strategic Approaches by Key Players:
Guardant Health, Inc., Trovagene, Inc., Agena Bioscience Inc. Inc., Admera Health, Biocept, Inc., Circulogene Theranostics, Inivata Ltd., SAGA Diagnostics AB, Exosome Diagnostics, and Bio-Rad Laboratories, Inc., Agena Bioscience Inc. Inc. are major players in the liquids biopsy market. The key players in the market are focusing on the development of new diagnostics methods and tools, as well as various strategic approaches such as acquisitions, partnership, and collaboration. Fund raising for cancer research is one to the important tasks for the key players to development new diagnostics devices and technologies as well as hold their position in the market.
Driver & Restrains
Increasing awareness about personalized cancer care is ruling the global liquid biopsy market. The market is driven by increasing demand for non-invasive testing, increasing prevalence of cancer, and extensive research and development in the cancer diagnosis and treatment. The market is also driven by number of advantages of liquid biopsies such as quick analysis, identification of specific mutations, low cost, and r less labor required. Furthermore, rising awareness about the diagnosis of various types of cancer stimulate the market growth. However, tumor heterogeneity, remaining the biggest challenge in cancer research, may restrain the growth of the market.
Liquid Biopsy Market Segments:
Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centers and others.
Regional Analysis of Global Liquid Biopsy Market:
Globally North America is the largest market for Global Liquid Biopsy market. Europe is the second-largest market for Global Liquid Biopsy market. However the developing regions market particularly Asia Pacific will be the fastest growing and will be the key to the future. North America accounted for the largest market share of 37.95% in 2016 accounting for a market value of 1,499.10 million in 2016. Asia pacific is the fastest growing market which is growing at a CAGR of 28.8%.
Get Discount @ https://www.marketresearchfuture.com/check-discount/710 .
Major TOC For Global Liquid Biopsy Market Research Report- Forecast to 2022:
1 REPORT PROLOGUE
2.1 Scope Of Study
2.2 Research Objective
2.3 Assumptions & Limitations
2.4 Market Structure
3 RESEARCH METHODOLOGY
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
4 MARKET DYNAMICS
4.2.1 Comparatively Painless And Non-Invasive Technique
4.2.2 Early Real Time High Precision Detection Of Diseases
4.2.3 Useful For Designing Effective Treatment Strategies Based On The Real Time Molecular Assessment For The Progression Of The Disease
LIST OF TABLES
TABLE 1 GLOBAL LIQUID BIOPSY MARKET BY BIOMARKER TYPE, $ MILLION (2016-2022)
TABLE 2 CIRCULATING TUMOR CELLS (CTCS) MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 3 CIRCULATING TUMOUR DNA (CTDNA) MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 4 EXTRACELLULAR VESICLES (EVS) MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 5 OTHER BIOMARKER TYPE MARKET, BY REGION, 2014-2022 ($ MILLION)
TABLE 6 GLOBAL LIQUID BIOPSY MARKET BY THERAPEUTIC APPLICATIONS, 2014-2022 ($ MILLION)
Ask to Expert @ https://www.marketresearchfuture.com/enquiry/710 .
LIST OF FIGURES
FIGURE 1 GLOBAL LIQUID BIOPSY: MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS OF MRFR
FIGURE 3 GLOBAL LIQUID BIOPSY: PORTER FIVE FORCES ANALYSIS
FIGURE 4 GLOBAL LIQUID BIOPSY MARKET, BY BIOMARKER TYPE, MARKET SHARE 2016 (%)
FIGURE 5 GLOBAL LIQUID BIOPSY MARKET BY BIOMARKER TYPE, 2016 $ MILLION
FIGURE 6 CIRCULATING TUMOR CELLS (CTCS) MARKET, BY REGION, 2016, $ MILLION
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar